SAN FRANCISCO — Edwards LifeSciences says its competitor Medtronic won’t take yes for an answer.
Urging the U.S. Court of Appeals for the Federal Circuit to leave a controversial preliminary injunction in place, Edwards said in a filing Thursday that it’s willing to let Medtronic supply its own artificial heart valves to patients who can’t be treated with Edwards’ patented version.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
